Savient (SVNT) Increases Price on KRYSTEXXA to $5,390

Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced today that it increased the price per vial for KRYSTEXXA to $5,390, effective for orders placed after 5:00 p.m. Eastern Standard Time on May 17, 2013. The Company will continue to evaluate the pricing of KRYSTEXXA, as continued substantial price increases will, in light of the current market dynamics for KRYSTEXXA, be necessary in the Company's effort to obtain sufficient revenue from KRYSTEXXA. The Company will have no duty to make public disclosure of price increases.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FOMC minutes from July 28-29th meeting
• Morgan Stanley raises 2026 commercial real estate volume forecast
• HSBC Downgrades Gerdau S.A. (GGBR4:BZ) (GGB) to Hold